Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,962,698
+$1,236,499 QoQ
Shares Held
240,868
-1.1% QoQ
Ownership
0.307%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#57
of 252 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Dec 31, 2023CallValue
$4,588,662
CallShares
115,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $446,413,848 across 71 Biotechnology names. CLDX ranks #14 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,469,971 | $39,659,817 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
1,014,606 | $22,179,287 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
588,494 | $19,649,814 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
328,550 | $18,799,631 | |
| 5 | CYTK |
Cytokinetics Inc
|
219,987 | $18,740,692 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
245,346 | $18,273,370 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
459,340 | $17,776,458 | |
| 8 | INSM |
INSMED Inc
|
118,800 | $12,666,456 |
All Filings in CLDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,962,698 | 240,868 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,726,199 | 243,575 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,511,990 | 239,764 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,374,854 | 207,764 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,537,639 | 419,540 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,217,096 | 507,829 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,980,582 | 474,103 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,245,310 | 419,103 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,445,897 | 309,265 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,625,522 | 276,996 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,588,662 | 115,700 | Call | Defined | 2024-02-15 | |
| 2023-12-31 | $12,518,441 | 315,644 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $2,752,000 | 100,000 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $4,953,600 | 180,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,428,800 | 160,000 | Shares | Defined | 2023-08-14 | |
| 2021-12-31 | $6,443,838 | 166,766 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,036,516 | 130,330 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $4,538,592 | 220,320 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,462,908 | 597,198 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,487,100 | 370,000 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||